Business
PDMR Shareholdings
PDMR Shareholdings.
About this update from Diaceutics Plc
[{"type":"text","content":"\n\n11 May 2023\n \nDiaceutics PLC\n(\"Diaceutics\" or \"the Company\")\n \nPDMR shareholdings\n \nDiaceutics PLC, (AIM: DXRX), a leading technology and solutions provider to the pharmaceutical industry, has been informed that Jordan Clark, Chief Commercial Officer, a Person Discharging Managerial Responsibilities ('PDMR'), has on 4 May 2023 sold 50,000 Ordinary Shares in the Company each, at a price of 98 pence per Ordinary Share. This is the last sale in a tranche of shares currently being sold by Jordan Clark.\n \n \nEnquiries:\n \n\n\n\nDiaceutics PLC \n\n\n\n\n\n\n\nPeter Keeling, Chief Executive Officer\nNick Roberts, Chief Financial Officer \n\n\nVia Alma PR \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nStifel Nicolaus Europe Limited (Nomad & Broker)\n\n\nTel: +44 (0)20 7710 7600\n\n\n\n\nBen Maddison\n\n\n\n\n\n\n\nNick Harland\n\n\n\n\n\n\n\nNick Adams\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nAlma PR\n\n\nTel: +44(0)20 3405 0205\n\n\n\n\nCaroline Forde\n\n\[email protected]\n\n\n\n\nKieran Breheny\n\n\n\n\n\n\n\nMatthew Young\nKinvara Verdon\n\n\n\n\n\n\n \n \nAbout Diaceutics\n \nAt Diaceutics we believe that every patient should get the opportunity to receive the right test and the right therapy to positively impact their disease outcome. We provide the world's leading pharmaceutical and life science companies with solutions and technology for the commercialisation of their precision medicines, enabled by the proprietary DXRX platform.\n \nDXRX is the world's first diagnostic commercialisation platform for precision medicine, utilising a global network of affiliate laboratories to deliver multiple pipelines of real-world healthcare data insights, advisory services and innovative platform enabled solutions.\n \n \n\n\n\nNotification of a Transaction pursuant to Article 19(1) of Regulation (EU) No. 596/2014\n\n\n\n\n1\n\n\nDetails of the person discharging managerial responsibilities/person closely associated\n\n\n\n\na.\n\n\nName\n\n\nJordan Clark\n\n\n\n\n2\n\n\nReason for notification\n\n\n\n\n\n\n\na.\n\n\nPosition/Status\n\n\nChief Commercial Officer\n\n\n\n\nb.\n\n\nInitial notification/\nAmendment\n\n\nInitial\n\n\n\n\n3\n\n\nDetails of the issuer, emission allowance market participant, auction platfo...